Chularat Hospital PCL (BKK:CHG)
Thailand
· Delayed Price · Currency is THB 1.480
-0.020 (-1.33%)
At close: Mar 6, 2026
Chularat Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 8,347 | 8,237 | 7,730 | 10,103 | 11,742 | Upgrade
|
| Other Revenue | 70.51 | 243.52 | 284.13 | 304.57 | 257.29 | Upgrade
|
| Revenue | 8,417 | 8,480 | 8,014 | 10,408 | 11,999 | Upgrade
|
| Revenue Growth (YoY) | -0.74% | 5.81% | -22.99% | -13.26% | 119.70% | Upgrade
|
| Cost of Revenue | 5,974 | 6,068 | 5,631 | 5,908 | 5,882 | Upgrade
|
| Gross Profit | 2,444 | 2,413 | 2,384 | 4,500 | 6,117 | Upgrade
|
| Selling, General & Admin | 1,192 | 1,127 | 1,003 | 934.88 | 821.27 | Upgrade
|
| Operating Expenses | 1,192 | 1,127 | 1,003 | 934.88 | 821.27 | Upgrade
|
| Operating Income | 1,252 | 1,286 | 1,381 | 3,565 | 5,296 | Upgrade
|
| Interest Expense | -27.52 | -34.52 | -24 | -16.28 | -21.38 | Upgrade
|
| Interest & Investment Income | 10.52 | 14.11 | 8.66 | 6.08 | 1.9 | Upgrade
|
| Earnings From Equity Investments | -13.35 | -20.07 | -19.35 | -1.11 | - | Upgrade
|
| Pretax Income | 1,222 | 1,245 | 1,346 | 3,554 | 5,276 | Upgrade
|
| Income Tax Expense | 251.26 | 267.26 | 279.09 | 703.37 | 1,009 | Upgrade
|
| Earnings From Continuing Operations | 970.25 | 977.96 | 1,067 | 2,850 | 4,267 | Upgrade
|
| Minority Interest in Earnings | -40.88 | -12.74 | -21.21 | -71.68 | -63.22 | Upgrade
|
| Net Income | 929.37 | 965.22 | 1,046 | 2,778 | 4,204 | Upgrade
|
| Net Income to Common | 929.37 | 965.22 | 1,046 | 2,778 | 4,204 | Upgrade
|
| Net Income Growth | -3.71% | -7.73% | -62.35% | -33.91% | 379.58% | Upgrade
|
| Shares Outstanding (Basic) | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 | Upgrade
|
| Shares Outstanding (Diluted) | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 | Upgrade
|
| EPS (Basic) | 0.08 | 0.09 | 0.10 | 0.25 | 0.38 | Upgrade
|
| EPS (Diluted) | 0.08 | 0.09 | 0.10 | 0.25 | 0.38 | Upgrade
|
| EPS Growth | -3.71% | -7.73% | -62.35% | -33.91% | 379.58% | Upgrade
|
| Free Cash Flow | 985.48 | 1,128 | 987.1 | 1,843 | 3,525 | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.10 | 0.09 | 0.17 | 0.32 | Upgrade
|
| Dividend Per Share | 0.070 | 0.070 | 0.070 | 0.160 | 0.200 | Upgrade
|
| Dividend Growth | - | - | -56.25% | -20.00% | 300.00% | Upgrade
|
| Gross Margin | 29.03% | 28.45% | 29.74% | 43.23% | 50.98% | Upgrade
|
| Operating Margin | 14.87% | 15.16% | 17.23% | 34.25% | 44.13% | Upgrade
|
| Profit Margin | 11.04% | 11.38% | 13.05% | 26.70% | 35.04% | Upgrade
|
| Free Cash Flow Margin | 11.71% | 13.30% | 12.32% | 17.71% | 29.38% | Upgrade
|
| EBITDA | 1,724 | 1,749 | 1,797 | 3,921 | 5,623 | Upgrade
|
| EBITDA Margin | 20.48% | 20.62% | 22.42% | 37.67% | 46.86% | Upgrade
|
| D&A For EBITDA | 471.93 | 463.31 | 415.65 | 355.71 | 327.11 | Upgrade
|
| EBIT | 1,252 | 1,286 | 1,381 | 3,565 | 5,296 | Upgrade
|
| EBIT Margin | 14.87% | 15.16% | 17.23% | 34.25% | 44.13% | Upgrade
|
| Effective Tax Rate | 20.57% | 21.46% | 20.73% | 19.79% | 19.12% | Upgrade
|
| Revenue as Reported | 8,417 | 8,480 | 8,014 | 10,408 | 11,999 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.